Article Information
History
- January 29, 2022.
Article Versions
- You are currently viewing Version 1 of this article (January 29, 2022 - 00:48).
- Version 2 (March 7, 2022 - 11:36).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Janmejay Singh1,*,
- Heena Shaman1,*,
- Balwant Singh1,*,
- Anbalagan Anantharaj1,
- Kamal Pargai1,
- Partha Chattopadhyay3,4,
- Priti Devi3,4,
- Ranjeet Maurya3,4,
- Pallavi Mishra3,
- Namrata Kahlon2,
- Rajesh Pandey3,
- Anil Kumar Pandey2 and
- Guruprasad R. Medigeshi1,#
- 1Bioassay Laboratory, Translational Health Science and Technology Institute, Faridabad, Haryana. INDIA
- 2Employees State Insurance Corporation Medical College and Hospital, Faridabad, Haryana, INDIA
- 3INtegrative GENomics of HOst-PathogEn (INGEN-HOPE) laboratory, CSIR-Institute of Genomics and Integrative Biology, Delhi, INDIA
- 4Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India
- ↵#Corresponding author:
Guruprasad R. Medigeshi, PhD, Translational Health Science and Technology Institute, P.O. Box # 4, Faridabad-Gurgaon Highway, Faridabad 121001. INDIA., Tel: +91-0129-2876311. Email: gmedigeshi{at}thsti.res.in
↵* These authors contributed equally
Posted January 29, 2022.
Hybrid immunity from SARS-CoV-2 delta variant surge induced low to undetectable levels of neutralizing antibodies against Omicron variant
